Affordable Access

deepdyve-link
Publisher Website

Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics.

Authors
  • Jain, Richa1
  • Jain, Ankit2
  • Verma, Santosh Kumar3
  • 1 Institute of Engineering and Technology, Lucknow, Uttar Pradesh India. , (India)
  • 2 Indian Meteorological Department, Lucknow, India. , (India)
  • 3 Department of Civil Engineering, National Institute of Technology, Hamirpur, India. , (India)
Type
Published Article
Journal
International Journal of Peptide Research and Therapeutics
Publisher
Springer Nature
Publication Date
Apr 16, 2021
Pages
1–12
Identifiers
DOI: 10.1007/s10989-021-10205-z
PMID: 33897313
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

COVID-19 is an infectious disease caused by a newly discovered corona virus SARS-COV-2. It is the most dangerous epidemic existing currently all over the world. To date, there is no licensed vaccine and not any particular efficient therapeutic agent available to prevent or cure the disease. So development of an effective vaccine is the urgent need of the time. The proposed study aims to identify potential vaccine candidates by screening the complete proteome of SARS-COV-2 using the computational approach. From 14 protein entries in UniProtKB, 4 proteins were screened for epitope prediction based on consensus antigenicity predictions and various physico-chemical criteria like transmembrane domain, allergenicity, GRAVY value, toxicity, stability index. Comprehensive analysis of these 4 antigens revealed that spike protein (P0DTC2) and nucleoprotein (P0DTC9) show the greatest potential for experimental immunogenicity analysis. These 2 proteins have several potential CD4+ and CD8+ T-cell epitopes, as well as high probability of B-cell epitope regions as compared to well-characterized antigen the matrix protein 1 [Influenza A virus (H5N1)]. In addition, the epitope SIIAYTMSL predicted from spike protein (P0DTC2) and epitope SPRWYFYYL predicted from nucleoprotein (P0DTC9) exhibited more than 60% population coverage in the target populations Europe, North America, South Asia, Northeast Asia taken in this study. These epitopes have also been found to exhibit highly significant TCR-pMHC interactions having a joint Z value of 4.51 and 4.37 respectively. Therefore, this analysis suggests that the predicted epitopes might be suitable vaccine candidates and should be subjected to further in-vivo and in-vitro studies. © The Author(s), under exclusive licence to Springer Nature B.V. 2021.

Report this publication

Statistics

Seen <100 times